Minafin invests €14.5M ($18M) in extension of Minakem’s production capacity in France

March 15th, 2018|

Minafin invests €14.5M ($18M) in extension of Minakem’s production capacity in France

With 25 per cent increase, Dunkirk site will boast 54m3 capacity extension, allowing contract […]

Minakem upgrades containment for High Potent API

October 16th, 2017|

Minakem upgrades containment for High Potent API

Minakem has initiated an ambitious investment plan for setting up equipments with the highest level of containment required to develop and produce highly potent molecules such as Antibody-drug […]

Minakem invests in Chromatography

June 12th, 2017|

Minakem invests in Chromatography

Minakem, Minafin Group’s arm dedicated to the chemical development and manufacturing for the pharmaceutical industry, and the supply of associated services for […]

Minafin group’s headquarters relocated to Louvain-la-Neuve site in Belgium

November 23rd, 2016|

Minafin group’s headquarters relocated to Louvain-la-Neuve site in Belgium

Since July 29th, Minafin S.à.r.l., the mother company of Minafin group that used to be a Luxembourg company, has acquired the Belgium nationality as a SPRL […]

Successful FDA inspections

September 25th, 2015|

Successful FDA inspection in September 2015

Since the beginning of API production activities, the site has a long and successful track record of health authorities’ inspections.

Minakem High Potent is very pleased to announce that our […]

MINAKEM High Potent SA

June 8th, 2015|

MINAKEM High Potent SA

Louvain-la-Neuve Plant, Belgium, 01 June 2015

MINAFIN enters the business of High Potent APIs and controller substances, and reorganizes its niche technologies business units

The Minafin Group has just acquired the Louvain-La-Neuve (Belgium) […]